Drenckhan A - Search Results

1

Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.

Ameis HM, Drenckhan A, Freytag M, Izbicki JR, Supuran CT, Reinshagen K, Holland-Cunz S, Gros SJ. Ameis HM, et al. Among authors: drenckhan a. J Enzyme Inhib Med Chem. 2016;31(3):404-9. doi: 10.3109/14756366.2015.1029471. Epub 2015 Apr 17. J Enzyme Inhib Med Chem. 2016. PMID: 25884234 Free article.

2

PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.

Ameis HM, Drenckhan A, von Loga K, Escherich G, Wenke K, Izbicki JR, Reinshagen K, Gros SJ. Ameis HM, et al. Among authors: drenckhan a. PLoS One. 2013 Dec 20;8(12):e83701. doi: 10.1371/journal.pone.0083701. eCollection 2013. PLoS One. 2013. PMID: 24376734 Free PMC article.

3

Influence of hypoxia-dependent factors on the progression of neuroblastoma.

Ameis HM, Drenckhan A, Freytag M, Izbicki JR, Supuran CT, Reinshagen K, Holland-Cunz S, Gros SJ. Ameis HM, et al. Among authors: drenckhan a. Pediatr Surg Int. 2016 Feb;32(2):187-92. doi: 10.1007/s00383-015-3831-8. Epub 2015 Oct 28. Pediatr Surg Int. 2016. PMID: 26510737

4

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.

Drenckhan A, Freytag M, Supuran CT, Sauter G, Izbicki JR, Gros SJ. Drenckhan A, et al. J Enzyme Inhib Med Chem. 2018 Dec;33(1):1024-1033. doi: 10.1080/14756366.2018.1475369. J Enzyme Inhib Med Chem. 2018. PMID: 29865880 Free PMC article.

5

Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer.

Drenckhan A, Kurschat N, Dohrmann T, Raabe N, Koenig AM, Reichelt U, Kaifi JT, Izbicki JR, Gros SJ. Drenckhan A, et al. J Surg Res. 2013 Jun 15;182(2):250-6. doi: 10.1016/j.jss.2012.09.035. Epub 2012 Oct 10. J Surg Res. 2013. PMID: 23117118

6

Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib.

Drenckhan A, Grob T, Dupree A, Dohrmann T, Mann O, Izbicki JR, Gros SJ. Drenckhan A, et al. Langenbecks Arch Surg. 2014 Oct;399(7):879-88. doi: 10.1007/s00423-014-1235-1. Epub 2014 Jul 29. Langenbecks Arch Surg. 2014. PMID: 25070024

7

Metastatic Esophageal Carcinoma Cells Exhibit Reduced Adhesion Strength and Enhanced Thermogenesis.

Huo Z, Sá Santos M, Drenckhan A, Holland-Cunz S, Izbicki JR, Nash MA, Gros SJ. Huo Z, et al. Among authors: drenckhan a. Cells. 2021 May 16;10(5):1213. doi: 10.3390/cells10051213. Cells. 2021. PMID: 34065626 Free PMC article.

8

CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.

Gros SJ, Graeff H, Drenckhan A, Kurschat N, Blessmann M, Rawnaq T, Izbicki JR. Gros SJ, et al. Among authors: drenckhan a. In Vivo. 2012 Jul-Aug;26(4):711-8. In Vivo. 2012. PMID: 22773586

9

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.

Gros SJ, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Effenberger K, Reichelt U, Hoffman RM, Pantel K, Kaifi JT, Izbicki JR. Gros SJ, et al. Among authors: drenckhan a. PLoS One. 2012;7(10):e47287. doi: 10.1371/journal.pone.0047287. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082154 Free PMC article.

10

ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy concepts.

Kebenko M, Drenckhan A, Gros SJ, Jücker M, Grabinski N, Ewald F, Grottke A, Schultze A, Izbicki JR, Bokemeyer C, Wellbrock J, Fiedler W. Kebenko M, et al. Among authors: drenckhan a. Cell Signal. 2015 Feb;27(2):373-81. doi: 10.1016/j.cellsig.2014.11.022. Epub 2014 Nov 27. Cell Signal. 2015. PMID: 25435423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters